UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Personalizing NSCLC therapy by characterizing tumors using TKI-PET and immuno-PET

Lung cancer (Amsterdam, Netherlands), 2017-05, Vol.107, p.1-13

2017

Volltextzugriff (PDF)

PO-0785: 89Zr-Cetuximab uptake in primary head and neck xenografts is independent of the expression of EGFR and perfusion

Radiotherapy and oncology, 2014, Vol.111, p.S53-S54

2014

Volltextzugriff (PDF)

PMD61 Cost-Effectiveness of Positron Emission Tomography in Head and Neck Squamous Cell Carcinoma: A Systematic Review

Value in health, 2012-11, Vol.15 (7), p.A355-A356

2012

Volltextzugriff (PDF)

Disparity Between In Vivo Zirconium-89-Labeled Cetuximab Uptake and EGFR Expression

International journal of radiation oncology, biology, physics, 2007-11, Vol.69 (3), p.S150-S150

2007

Volltextzugriff (PDF)

A phase I dose escalation study with anti-CD44V6 bivatuzumab mertansine in patients with incurable squamous cell carcinoma of the head and neck or esophagus

Radiotherapy and oncology, 2007, Vol.82, p.S29-S30

2007

Volltextzugriff (PDF)

Immuno-pet with zirconium-89-labeled chimeric monoclonal antibody U36 in the detection of lymph node metastases in head and neck cancer patients

Radiotherapy and oncology, 2007, Vol.82, p.S36-S36

2007

Volltextzugriff (PDF)

First-in-human imaging of nanoparticle entrapped docetaxel (CPC634) in patients with advanced solid tumors using 89 Zr-Df-CPC634 PET/CT

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.3093-3093

2019

Volltextzugriff (PDF)

Photosensitizer-antibody conjugates for detection and therapy of cancer

Advanced drug delivery reviews, 2004-01, Vol.56 (1), p.31-52

2004

Volltextzugriff (PDF)

Pharmacokinetics of cetuximab and tumor uptake of 89 Zr-cetuximab as potential predictive biomarkers for benefit of cetuximab in patients with advanced colorectal cancer

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e15117-e15117

2017

Volltextzugriff (PDF)

Whole body PD-L1 PET in patients with NSCLC and melanoma

Journal of clinical oncology, 2018-02, Vol.36 (5_suppl), p.139-139

2018

Volltextzugriff (PDF)

Whole body PD-1 and PD-L1 PET with 89 Zr-nivolumab and 18 F- BMS-986192 in pts with NSCLC

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e20047-e20047

2017

Volltextzugriff (PDF)

Molecular Therapeutics in Head and Neck Squamous Cell Carcinoma: A Systematic Review of Cost-Effectiveness Analyses

Annals of oncology, 2012-09, Vol.23, p.ix450

2012

Volltextzugriff (PDF)

ImmunoPET imaging with 89 Zr-cetuximab in patients with advanced colorectal cancer

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.11102-11102

2014

Volltextzugriff (PDF)

PET/CT with 89Zr-trastuzumab and 18F-FDG to individualize treatment with trastuzumab emtansine (T-DM1) in metastatic HER2-positive breast cancer (mBC)

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.11001-11001

2014

Volltextzugriff (PDF)

S9 Molecular diagnosis: current prospects

Oral oncology. Supplement, 2007-05, Vol.2 (1), p.68-68

van Dongen, G.A.M.S.

2007

Volltextzugriff (PDF)

How we do it: Chemo-electroporation in the head and neck for otherwise untreatable patients

Clinical otolaryngology, 2006-10, Vol.31 (5), p.447-451

2006

Volltextzugriff (PDF)

The Role of Apoptosis in Antibody-Dependent Cell-Mediated Cytotoxicity against Monolayers of Human Squamous Cell Carcinoma of the Head and Neck Targets

Cellular immunology, 1996-07, Vol.171 (1), p.20-29

1996

Volltextzugriff (PDF)

Antitumor activity of brequinar sodium (Dup-785) against human head and neck squanmous cell carcinoma xenografts

Cancer letters, 1990, Vol.49 (2), p.133-137

1990

Volltextzugriff (PDF)

High resolution PET imaging characteristics of /sup 68/Ga, /sup 124/I and /sup 89/Zr compared to /sup 18/F

IEEE Nuclear Science Symposium Conference Record, 2005, 2005, Vol.3, p.1624-1627

2005

Volltextzugriff (PDF)

Targeting of photosensitizers to head and neck tumours by the use of monoclonal antibodies

Clinical otolaryngology and allied sciences, 2001-08, Vol.26 (4), p.339-339

2001

Volltextzugriff (PDF)

Optimization and Simplification of Expression Cloning in Eukaryotic Vector/Host Systems

Analytical biochemistry, 1994-05, Vol.218 (2), p.460-463

1994

Volltextzugriff (PDF)

1 – 21 von 21

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(18)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(20)
Tagungsberichte
(1)

Sprache

Englisch
(21)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Personalizing NSCLC therapy by characterizing tumors using TKI-PET and immuno-PET

PO-0785: 89Zr-Cetuximab uptake in primary head and neck xenografts is independent of the expression of EGFR and perfusion

PMD61 Cost-Effectiveness of Positron Emission Tomography in Head and Neck Squamous Cell Carcinoma: A Systematic Review

Disparity Between In Vivo Zirconium-89-Labeled Cetuximab Uptake and EGFR Expression

A phase I dose escalation study with anti-CD44V6 bivatuzumab mertansine in patients with incurable squamous cell carcinoma of the head and neck or esophagus

Immuno-pet with zirconium-89-labeled chimeric monoclonal antibody U36 in the detection of lymph node metastases in head and neck cancer patients

First-in-human imaging of nanoparticle entrapped docetaxel (CPC634) in patients with advanced solid tumors using 89 Zr-Df-CPC634 PET/CT

Photosensitizer-antibody conjugates for detection and therapy of cancer

Pharmacokinetics of cetuximab and tumor uptake of 89 Zr-cetuximab as potential predictive biomarkers for benefit of cetuximab in patients with advanced colorectal cancer

Whole body PD-L1 PET in patients with NSCLC and melanoma

Whole body PD-1 and PD-L1 PET with 89 Zr-nivolumab and 18 F- BMS-986192 in pts with NSCLC

Molecular Therapeutics in Head and Neck Squamous Cell Carcinoma: A Systematic Review of Cost-Effectiveness Analyses

ImmunoPET imaging with 89 Zr-cetuximab in patients with advanced colorectal cancer

PET/CT with 89Zr-trastuzumab and 18F-FDG to individualize treatment with trastuzumab emtansine (T-DM1) in metastatic HER2-positive breast cancer (mBC)

S9 Molecular diagnosis: current prospects

How we do it: Chemo-electroporation in the head and neck for otherwise untreatable patients

The Role of Apoptosis in Antibody-Dependent Cell-Mediated Cytotoxicity against Monolayers of Human Squamous Cell Carcinoma of the Head and Neck Targets

Antitumor activity of brequinar sodium (Dup-785) against human head and neck squanmous cell carcinoma xenografts

High resolution PET imaging characteristics of /sup 68/Ga, /sup 124/I and /sup 89/Zr compared to /sup 18/F

Targeting of photosensitizers to head and neck tumours by the use of monoclonal antibodies

Optimization and Simplification of Expression Cloning in Eukaryotic Vector/Host Systems

Suchergebnisse filtern